Clinical Trials Logo

Hepatobiliary Cancers Liver clinical trials

View clinical trials related to Hepatobiliary Cancers Liver.

Filter by:
  • None
  • Page 1

NCT ID: NCT01071434 Terminated - Lung Cancer Clinical Trials

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Start date: February 2009
Phase: N/A
Study type: Observational

This study aims to investigate and optimize imaging sequences and parameters of rapid real-time MRI in order to obtain adequate guidance for accurately and precisely delivering radiation to moving abdominal and thoracic tumors.

NCT ID: NCT01031056 Withdrawn - Pancreatic Cancer Clinical Trials

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Start date: January 2010
Phase: N/A
Study type: Observational

We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers. PRIMARY OBJECTIVES: 1. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers. SECONDARY OBJECTIVES: 1. Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories 2. Collect details about the tumor specimen extracted from patient charts.

NCT ID: NCT00768001 Terminated - Hepatitis C Clinical Trials

Genetic Analysis of Liver Cancer

Start date: June 2008
Phase: N/A
Study type: Observational

Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of liver cancer influences clinical outcome and treatment response. We are developing a translational research program that will characterize molecular changes in liver cancer. We plan to use molecular information obtained from studying liver tumor tissues to develop new diagnostics and treatment regimens for patients with these cancers. The experimental approach will require freezing fresh tumor tissues obtained from surgical procedures, which will be subsequently used for analysis of DNA, protein and mRNA expression. Many patients with liver cancer are referred to the Stanford Liver Tumor Board for consultation and treatment recommendations. We propose to gather tissue samples from those who subsequently undergo biopsy, liver resection surgery, or transplant surgery.

NCT ID: NCT00767936 Terminated - Hepatitis C Clinical Trials

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Start date: March 2008
Phase: N/A
Study type: Observational

Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.